Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Tatva Chintan Pharma Chem Ltd - 543321 - Intimation For Updation In Website
Pursuant to Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we would like to inform you that we have revamped our website i.e. www.tatvachintan.com, which is more user and Investor Friendly. Request you to please take the above on record. Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we hereby submit schedule of analyst/institutional investors meeting that the Company would be participating: Date Particulars Type Mode 2 February 2022 HDFC MF One-on-One Virtual meeting Please note that the above may subject to change, if any. Kindly take the above disclosure on your records. Tatva Chintan Pharma Chem Ltd - 543321 - Corrigendum To NOTES To Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended On December 31, 2021.
With reference to above mentioned subject, we would like to inform you that there is typographical error in point no. 6 of notes to Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended on December 31, 2021. The respective correction does not have any impact on financial figure/results/XBRL. Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed herewith the transcript of the earnings call held on January 18, 2022 post announcement of financial results of the Company for the quarter and nine months ended December 31, 2021. The same will be uploaded on the Company''s website. This is for your information and records. Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed a copy of the Monitoring agency report of the Company for the quarter ended December 31, 2021, issued by ICICI Bank Limited, appointed to monitor the utilization of proceeds of an Initial Public Offering ('IPO') of the Company. Kindly take the above information on your record. Tatva Chintan Pharma Chem Ltd - 543321 - Statement Of Deviation / Variation In Utilization Of Funds Raised Through IPO
Pursuant to Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed herewith statement of deviation(s) or variation(s) in utilization of funds raised through Initial Public Offering (IPO) for the quarter ended December 31, 2021 in the prescribed format. The same will be filed in XBRL mode separately. We confirm that, as at December 31, 2021, there has not been any deviation(s) or variation(s) in the utilization of net proceeds of IPO as mentioned in the objects stated in the Prospectus dated July 22, 2021. Monitoring agency report issued in this regard is being separately filed with the exchange. Kindly take the above information on your record.
Earnings Call for Q3FY22 of Tatva Chintan Pharma Chem
Conference Call with Tatva Chintan Pharma Chem Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript. Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation
We hereby enclosed Investor Presentation for the quarter and nine months ended December 31, 2021. The same will be uploaded on the Company's website. This is for your information and records. Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are enclosing herewith copies newspaper publication of extract of unaudited financial results of the Company for the quarter and nine months ended on December 31, 2021, published in Financial Express (English edition) and Vadodara Samachar (Gujarati edition) on January 18, 2022. Kindly take the same on record and disseminate to the public at large.